Publications

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

 68
Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

Tags:

Previous Article

Timescapes of non-human experience

Next Article

Parkinson's medication shows promise in treating depression

Related Posts

Translatome profiling reveals opposing alterations in inhibitory and excitatory neurons of fragile X mice and identifies EPAC2 as a therapeutic target

Translatome profiling reveals opposing alterations in i...

 55

Emerging roles of the cGAS/STING pathway in cardiovascular diseases

Emerging roles of the cGAS/STING pathway in cardiovascu...

 43

Endurance exercise elicits temporal and sexual dimorphic multi-omics remodeling of liver metabolism revealed by MoTrPAC

Endurance exercise elicits temporal and sexual dimorphi...

 33